Cracking the tricuspid code "the Bicaval revolution"
Sponsored by P&F Products & Features
Symposium
P&F Products and Features
Simulation Learning Room
Anchorperson: Martin Swaans
Spokesperson: Rishi Puri
Discussants: Victoria Delgado, Philipp Nikolai, Matthew Price
Guest speakers: Nadira Hamid, Angel Sanchez Recalde
Watch this session if you want
- To discover how TricValve is providing answers in tricuspid regurgitation and right heart failure where no other therapies could
- To gain first-hand insights from real-world cases, clinical studies, and pioneering United States and European experiences with caval valve therapy
- To learn how imaging and innovative strategies, including rescue after failed interventions, are redefining patient selection and outcomes
Welcome and session objectives
Martin Swaans
Early feasibility, early answers: TRICAV-1 in the USA
Rishi Puri
Shaping the evidence: insights from the TricBicaval study
Angel Sanchez Recalde
Discussion and audience interaction
No case too complex: safe and effective TricValve therapy in real life
Matthew Price
From protocols to practice and long-term results: how TricValve is reshaping tricuspid regurgitation
Philipp Nikolai
TricValve best practices and the ESC/EACTS guidelines for the management of valvular heart disease
Nadira Hamid
Discussion and audience interaction
Session evaluation and key learnings
Martin Swaans